Calls
1
u/Rustic4748
Reddit r/pennystocks
Win Rate
0.0%
return
-49.1%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 22
$1.12
-49.1%
The author argues Humacyte is a real product company, not vaporware, with an FDA-approved product (Symvess) for vascular trauma and military injuries, backed by DoD/BARDA. He sees a multi-billion-dollar dialysis access indication with Phase 3 data and regulatory filings ahead as the key catalyst. The stock trades near all-time lows around $1 support, depressed by biotech dilution and risk-off sentiment, which he frames as asymmetric 5-10x upside on good news. He explicitly labels it high risk.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Rustic4748 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: HUMA.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
